Growth Metrics

Sonoma Pharmaceuticals (SNOA) Non-cash Items (2016 - 2025)

Sonoma Pharmaceuticals has reported Non-cash Items over the past 13 years, most recently at $39080.0 for Q4 2025.

  • For Q4 2025, Non-cash Items rose 24.93% year-over-year to $39080.0; the TTM value through Dec 2025 reached $39080.0, up 24.93%, while the annual FY2025 figure was $39751.0, 94.31% down from the prior year.
  • Non-cash Items for Q4 2025 was $39080.0 at Sonoma Pharmaceuticals, up from $35353.0 in the prior quarter.
  • Over five years, Non-cash Items peaked at $698454.0 in Q1 2024 and troughed at $28335.0 in Q3 2024.
  • A 5-year average of $248562.8 and a median of $197503.0 in 2022 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: surged 5305.84% in 2021 and later crashed 94.83% in 2024.
  • Year by year, Non-cash Items stood at $441549.0 in 2021, then tumbled by 51.39% to $214626.0 in 2022, then skyrocketed by 181.89% to $605000.0 in 2023, then crashed by 94.83% to $31282.0 in 2024, then increased by 24.93% to $39080.0 in 2025.
  • Business Quant data shows Non-cash Items for SNOA at $39080.0 in Q4 2025, $35353.0 in Q3 2025, and $39177.0 in Q2 2025.